Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Net Cash Flow (2017 - 2025)

Historic Net Cash Flow for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to -$10.0 million.

  • Arcus Biosciences' Net Cash Flow fell 12222.22% to -$10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.0 million, marking a year-over-year increase of 11764.71%. This contributed to the annual value of $23.0 million for FY2024, which is 12911.39% up from last year.
  • According to the latest figures from Q3 2025, Arcus Biosciences' Net Cash Flow is -$10.0 million, which was down 12222.22% from $56.0 million recorded in Q2 2025.
  • Arcus Biosciences' 5-year Net Cash Flow high stood at $401.0 million for Q1 2022, and its period low was -$276.0 million during Q2 2022.
  • In the last 5 years, Arcus Biosciences' Net Cash Flow had a median value of -$12.0 million in 2022 and averaged $3.5 million.
  • In the last 5 years, Arcus Biosciences' Net Cash Flow soared by 222857.6% in 2021 and then crashed by 37500.0% in 2023.
  • Over the past 5 years, Arcus Biosciences' Net Cash Flow (Quarter) stood at -$31.8 million in 2021, then surged by 62.29% to -$12.0 million in 2022, then plummeted by 375.0% to -$57.0 million in 2023, then grew by 10.53% to -$51.0 million in 2024, then skyrocketed by 80.39% to -$10.0 million in 2025.
  • Its last three reported values are -$10.0 million in Q3 2025, $56.0 million for Q2 2025, and $42.0 million during Q1 2025.